Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Immune Therapeutics, Inc. Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky September 14, 2023 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV August 29, 2023 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH August 15, 2023 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies April 20, 2023 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction March 01, 2023 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 (Toll Like Receptor 4) Antagonist JKB-122 Development November 09, 2022 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors September 27, 2022 From Immune Therapeutics, Inc. Via GlobeNewswire Tickers IMUN Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.